Are peptides legal in the US? A dated answer for 2026
Peptides are not controlled substances, and research use only sale is lawful when nothing points to use in people. Approval, compounding, supplements, import and sport, each dated.
Yes, with one condition. As of October 19, 2026, no peptide is a controlled substance under federal law, and we have found no state statute that bans research peptides as a class, so peptides can be bought and sold in the United States as research material. What federal law forbids is selling a peptide for use in people: once a seller's words, bundles or circumstances show that intent, the product is an unapproved new drug under the Federal Food, Drug, and Cosmetic Act, whatever the label says.
Seven questions hiding inside one
| The question people type | Short answer as of October 19, 2026 | Who decides |
|---|---|---|
| Is it a controlled substance? | No. The Controlled Substances Act's anabolic-steroid definition is built on testosterone chemistry and names no peptide. | DEA, 21 U.S.C. 802 |
| Can it be sold as research material? | Yes, if it is not intended for use in people. Intent is judged from claims and circumstances, not from the label. | FDA, FD&C Act sections 201(g), 201(p), 505(a) |
| Is any peptide an approved drug? | Some are, as specific products (bremelanotide, setmelanotide and octreotide, for example). Most research peptides are not. | FDA, Drugs@FDA |
| Can a pharmacy compound it? | Only if the substance meets one of three statutory conditions. Most research peptides meet none. | FDA and state boards of pharmacy, FD&C Act 503A |
| Can it be sold as a dietary supplement? | Not if it is an approved drug ingredient or a publicly investigated new drug that was not sold as food first. | FDA, 21 U.S.C. 321(ff) |
| Can it be imported? | FDA may detain it. Personal importation of unapproved drugs is, in FDA's words, illegal in most circumstances. | FDA and CBP, 21 U.S.C. 381 |
| Is it allowed in sport? | Many are prohibited at all times under the WADA list, regardless of FDA status. | WADA and national anti-doping agencies |
Are peptides controlled substances?
No. The Controlled Substances Act reaches "anabolic steroids," defined at 21 U.S.C. 802(41)(A) as "any drug or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progestins, corticosteroids, and dehydroepiandrosterone)," followed by a list of named steroid compounds. A peptide is a chain of amino acids joined by amide bonds. It is not chemically related to testosterone, a four-ring sterane, and no peptide appears in that definition; are peptides steroids sets the two structures side by side.
The statute that governs this market is the FD&C Act, and it turns on a definition. Under 21 U.S.C. 321(g)(1), a drug includes articles intended for medical use against disease in people or animals, and articles other than food intended to affect the structure or any function of the body.
Two words carry the weight: "intended for." A vial of lyophilized peptide is a chemical, and the same molecule can be a drug on one website and a research chemical on another. Once an article is a drug and not generally recognized as safe and effective, section 505(a) applies: no person may introduce it into interstate commerce without an approved application. The prohibited acts in 21 U.S.C. 331 are acts of commerce, which is why FDA's letters in this market go to sellers.
What "research use only" peptides means, and why the label does not settle it
"Research use only" describes a product sold as a chemical for laboratory work, with nothing that points to use in a person. It is a condition the seller has to keep, not a legal shield. FDA's regulation on intended use, 21 CFR 201.128, says intent "may be shown by such persons' expressions, the design or composition of the article, or by the circumstances surrounding the distribution of the article." The only place FDA's regulations define a "For Research Use Only" label is 21 CFR 809.10(c), which covers in vitro diagnostic products, not drugs.
FDA's letters to peptide sellers in 2024, 2025 and 2026 follow one pattern: the label is noted, then set aside because of what else the website shows. Five letters dated August 24, 2026 went to online peptide sellers whose products were labeled for research, among them NuScience Peptides:
evidence obtained from your website establishes that your products are intended to be drugs for human useFDA warning letter to NuScience Peptides LLC, August 24, 2026
So the answer to "can it be sold as research material" is yes, on a condition the seller controls entirely. How this site keeps it is in what "research use only" actually means, and what FDA reads on a website before it calls a research product a drug goes through the letters clause by clause.
Which peptides are FDA-approved drugs?
A handful of peptides are the active ingredient of an approved product, and for those "is it legal" has the ordinary answer: the approved product is lawful, through the channels its approval allows. Drugs@FDA lists, for example, Vyleesi (bremelanotide acetate, NDA 210557, approved June 21, 2019). Geref (sermorelin acetate, NDA 020443) was approved in 1997 and is listed as discontinued.
An approval belongs to the product, not to the molecule. A research vial of bremelanotide is not Vyleesi, is not made under the approved application, and cannot be represented as equivalent to it; FDA's 2026 letters name research-labeled GLP-1 class compounds, among other peptides, as unapproved new drugs for that reason. A compound that is still investigational has no approved product at all, and sold as a research chemical it is in the same position as any other unapproved peptide. Status for each peptide, row by row, is in approved, investigational, or neither.
Can a pharmacy compound peptides?
Section 503A lets a state-licensed pharmacy or physician compound from a bulk substance only if it has a USP or NF monograph, is a component of an FDA-approved drug, or appears on FDA's 503A bulks list. BPC-157, TB-500, KPV, MOTS-c, Semax, epitalon and the other peptides that dominate search meet none of the three. Their Category 2 nominations were withdrawn by the nominators on FDA's page dated April 22, 2026, which left them in no category: not in Category 1 and not on the bulks list.
FDA's Pharmacy Compounding Advisory Committee voted on seven of them on July 23 and 24, 2026, after FDA staff had proposed that none be listed. Press reports put BPC-157 at 8 in favor, 6 against, 1 abstaining; FDA has not posted a tally, and its own briefing document says it will not issue a final determination until the advisory process and its reviews are complete. Advisory votes are not binding, and adding a substance to the bulks list takes rulemaking. As of October 19, 2026 a search of the Federal Register finds no proposed rule. The sequence is in Category 1, Category 2 and the 503A bulks list, and the single most searched case is in BPC-157 in 2026.
Can peptides be sold as dietary supplements?
Not the ones people usually mean. The statutory definition of a dietary supplement, 21 U.S.C. 321(ff)(3)(B), excludes an article approved as a new drug, and an article "authorized for investigation as a new drug, antibiotic, or biological for which substantial clinical investigations have been instituted and for which the existence of such investigations has been made public," unless it was marketed as a supplement or food first. Approved GLP-1 class compounds fall under the first clause; a compound in public clinical trials falls under the second.
BPC-157 is a less settled case. FDA's July 2026 briefing document notes that it "is marketed in the United States as an ingredient in dietary supplement products formulated as oral capsules and tablets" and that there is no USP dietary supplement monograph for it. We have not found an FDA ruling on BPC-157 as a dietary ingredient, so this piece makes no claim either way.
Peptide laws by state: does any state ban research peptides?
As of October 19, 2026 we have not found a state statute that prohibits research peptides as a class. That is a search, not a legal opinion. What does apply at state level is the ordinary machinery: pharmacy practice acts and boards of pharmacy, which license 503A pharmacies; medical practice acts, which govern clinics; and consumer-protection statutes, which state attorneys general use against advertising claims. A research supplier is not a pharmacy or a clinic, and a clinic buying research material for use in people is on the wrong side of each of those regimes.
Can peptides be imported?
FDA's personal importation page answers it in one sentence:
In most circumstances, it is illegal for individuals to import drugs or devices into the U.S. for personal use because these products purchased from other countries often have not been approved by the FDA for use and sale in the U.S.FDA, Personal Importation, content current as of August 18, 2025
Import Alert 66-41, "Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.," lets FDA detain shipments from firms on its Red List without opening them; the release section asks the importer to show the shipment "does not contain unapproved new drug products." Its page is dated October 9, 2026. A separate alert, 66-80, covers GLP-1 receptor agonist bulk drug substances. The mechanics are in Import Alert 66-41 and research peptides.
Are peptides allowed in sport?
FDA status and sport status are separate systems. WADA's 2026 Prohibited List, in force from January 1, 2026, names BPC-157 under S0, the class for substances not approved by any government regulator, prohibited at all times. Section S2 names GHRH analogues, secretagogues and growth factors, CJC-1295, sermorelin, ipamorelin and TB-500 among them. WADA's 2027 list was approved on September 10, 2026 and takes effect January 1, 2027; we will update this section against its text. Placement by section is in where research peptides sit on the Prohibited List.
Everything in this catalog is sold as a chemical for laboratory research, with no use guidance, no calculators and no claims; that is the condition on which the research-material answer above stays a yes, and the practice is described under provenance.
Common questions
Are peptides legal in the US?
Yes, as research material, as of October 19, 2026. No peptide is a federally controlled substance and no state statute we found bans research peptides as a class. A peptide sold or promoted for use in a person is a drug under the FD&C Act, and an unapproved drug cannot lawfully be introduced into interstate commerce.
What does research use only mean for peptides?
It means the peptide is sold as a chemical for laboratory research, with nothing that points to use in a person. The label alone does not decide it: under 21 CFR 201.128, FDA reads intent from the seller's expressions, the product's design and the circumstances of sale, and its warning letters set the label aside when the website shows human use.
Does the Controlled Substances Act cover peptides?
No. It reaches anabolic steroids, defined as substances chemically and pharmacologically related to testosterone, and no peptide appears in that definition. The FD&C Act is the statute that governs this market.
Is BPC-157 on the WADA Prohibited List?
Yes. WADA's 2026 Prohibited List names BPC-157 as an example under S0, substances not approved by any government regulator, prohibited at all times. Sport status is separate from FDA status.
Sources
- 21 U.S.C. 321, Definitions (incl. 321(g)(1) and 321(ff)), Legal Information Institute, current
- PCAC meeting of July 23-24, 2026, FDA briefing document introduction, FDA, July 2026
- 21 U.S.C. 802, Definitions (Controlled Substances Act), Legal Information Institute, current
- 21 CFR 201.128, Meaning of "intended uses", govinfo, 2024 edition
- Warning letter to NuScience Peptides LLC, FDA, August 24, 2026
- Certain bulk drug substances for use in compounding that may present significant safety risks, FDA, content current as of April 22, 2026
- FDA briefing document for BPC-157-related bulk drug substances, FDA, July 2026
- Personal importation, FDA, content current as of August 18, 2025
- Import Alert 66-41, FDA, published October 9, 2026
- The 2026 Prohibited List, WADA, valid January 1, 2026
For laboratory research use only. Not a drug, not a supplement, and nothing here is a claim about what any of this material does in a person or an animal.
